Dr. Meller is originally from Adelaide, South Australia. He received his B.Sc., B.Sc. (Hons.), and PhD from the University of Adelaide. After travelling the world for a year, he spent 6 years at the University of Iowa, on the research faculty in Pharmacology studying the basic mechanisms underlying chronic pain before moving to the Procter and Gamble Company in 1994. Since moving there 14+ years ago, he has held various R&D roles in Health Care where he was ultimately responsible for the Health Care Technology and Clinical organizations. For the last 5 years, he has been in a corporate role where he is now on the leading edge for the global open innovation programs at P&G (Connect + DevelopSM; C+DSM).
In that role, he now serves as Chief Innovation Catalyst, in addition to leading the global technology innovators and entrepreneurs 'community of experts', the North American and Latin America open innovation hubs and several key business and technology platforms across the company. He regularly speaks on C+DSM around the globe. P&G has been recognized externally for its C+DSM by being listed as one of the top 10 most innovative companies in the world for the last 5 years. Also during that time, Dr. Meller has been a key driver on the technology strategy approaches for P&G's Sustainability and Industrial Biotechnology programs and its impact on global consumers. He regularly speaks on Industrial Biotechnology around the globe and its role in driving sustainability.
Stephen Meller will be presenting Open Innovation at EPIC Partnerships this October.
Bio courtesy of TechConnect